S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q3 2022

Baker Bros Advisors

Periodo: Q3 2022 Β· Depositato: 2022-11-14
Vedi su SEC EDGAR β†—
AUM
$15.27B
Valore totale del portafoglio
Posizioni
115
Titoli dichiarati
Prima Posizione
SGEN
42.0% $6.42B
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2022-11-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
SGENSeagen Inc.$6.42B42.04%β€”β€”
42.0%
INCYIncyte Corporation$2.41B15.78%$66.64$116.86+75.4%
15.8%
ONCBeiGene, Ltd.$1.57B10.30%$134.82$297.65+120.8%
10.3%
ACADACADIA Pharmaceuticals Inc.$685.9M4.49%$16.36$25.97+58.7%
4.5%
BMRNBioMarin Pharmaceutical Inc.$646.0M4.23%$84.77$58.99-30.4%
4.2%
ASNDAscendis Pharma A/S$501.1M3.28%$103.26$274.50+165.8%
3.3%
GBTGlobal Blood Therapeutics, Inc.$254.2M1.66%β€”β€”
1.7%
BCRXBioCryst Pharmaceuticals, Inc.$160.2M1.05%$12.60$9.84-21.9%
1.1%
RYTMRhythm Pharmaceuticals, Inc.$148.5M0.97%$24.50$114.17+366.0%
1.0%
KODKodiak Sciences Inc.$134.0M0.88%$7.74$38.54+397.9%
0.9%
IMCRImmunocore Holdings plc$118.3M0.77%$46.94$32.50-30.8%
0.8%
ABCLAbCellera Biologics Inc.$103.3M0.68%$9.89$8.11-18.0%
0.7%
ARGXargenx SE$98.9M0.65%$353.05$939.68+166.2%
0.7%
MRTXMirati Therapeutics, Inc.$98.5M0.64%β€”β€”
0.6%
MDGLMadrigal Pharmaceuticals, Inc.$97.4M0.64%$64.99$528.10+712.6%
0.6%
CCXIChemoCentryx, Inc.$92.6M0.61%β€”$19.10
0.6%
TVTXTravere Therapeutics, Inc.$81.3M0.53%$24.64$56.92+131.0%
0.5%
AKROAkero Therapeutics, Inc.$80.6M0.53%β€”β€”
0.5%
TRDAEntrada Therapeutics, Inc.$76.7M0.50%$15.76$7.72-51.0%
0.5%
IGMSIGM Biosciences, Inc.$71.8M0.47%β€”β€”
0.5%
REPLReplimune Group, Inc.$67.3M0.44%$17.27$11.58-33.0%
0.4%
PRLDPrelude Therapeutics Inc.$66.9M0.44%$6.61$4.91-25.7%
0.4%
KYMRKymera Therapeutics, Inc.$62.7M0.41%$21.77$113.51+421.4%
0.4%
HZNPHorizon Therapeutics Public Ltd Co$60.0M0.39%β€”β€”
0.4%
CERSCerus Corporation$57.8M0.38%$3.60$3.16-12.2%
0.4%
NRIXNurix Therapeutics, Inc.$50.6M0.33%$13.03$23.97+84.0%
0.3%
KDNYChinook Therapeutics, Inc.$49.8M0.33%β€”β€”
0.3%
VERVVerve Therapeutics, Inc.$48.7M0.32%β€”β€”
0.3%
IMTXImmatics N.V.$44.2M0.29%$10.00$9.95-0.5%
0.3%
FMTXForma Therapeutics Holdings, Inc.$37.6M0.25%β€”β€”
0.3%

AttivitΓ  Trimestre su Trimestre

Q3 2022 vs. Q2 2022

Nuove Posizioni (8)

TickerEmittenteNozionale
CINCCinCor Pharma, Inc.$26.5M
IDYAIDEAYA Biosciences, Inc.$24.9M
BCYCBicycle Therapeutics plc$19.6M
VERUXXXXVeru Inc.$18.5M
WHWKAadi Bioscience, Inc.$14.0M
PNTPOINT Biopharma Global Inc.$9.0M
KRONKronos Bio, Inc.$5.2M
FATEFate Therapeutics, Inc.$4.8M

Posizioni Chiuse (8)

TickerEmittenteNozionale
LEGNLegend Biotech Corporation$47.1M
Sarepta Therapeutics, Inc.$36.6M
MRUSMerus N.V.$22.5M
KRTXKaruna Therapeutics, Inc.$8.8M
HRMYHarmony Biosciences Holdings, Inc.$6.0M
CNTACentessa Pharmaceuticals plc$5.5M
EVFMEvofem Biosciences, Inc.$2.9M
BCABBioAtla, Inc.$2.4M

Aumentate (7)

TickerEmittenteNozionaleVar. AzioniDal Deposito
AKROAkero Therapeutics, Inc.$79.5M+1900.7%
RYTMRhythm Pharmaceuticals, Inc.$131.4M+47.0%+366.0%
VORXXXXVor Biopharma Inc.$0.2M+28.7%
REPLReplimune Group, Inc.$4.5M+8.4%-33.0%
OTICOtonomy, Inc.$-15.0M+0.4%
INCYIncyte Corporation$-337.3M+0.0%+75.4%
IMCRImmunocore Holdings plc$24.3M+0.0%-30.8%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
INSMInsmed Incorporated$-42.1M-99.1%
PACBPacific Biosciences of California, Inc.$-17.5M-79.3%
ARGXargenx SE$-325.3M-75.0%+166.2%
AMRNXXXXAmarin Corporation plc$-25.7M-74.6%
LOGCLogicBio Therapeutics, Inc.$-0.1M-69.2%
KRYSKrystal Biotech, Inc.$-23.6M-47.7%
ATYRaTyr Pharma, Inc.$-0.5M-46.2%
ALKSAlkermes plc$-26.5M-45.7%
← Torna agli Hedge Fund